Further reading Books

Crommelin, D. and Sindelar, R. 2002. Pharmaceutical Biotechnology, second edition. Taylor and Francis, London, UK.

Goldberg, R. 2001. Pharmaceutical Medicine, Biotechnology and European Law. Cambridge University Press. Grindley, J. and Ogden, J. 2000. Understanding Biopharmaceuticals. Manufacturing and Regulatory Issues. Interpharm Press.

Kayser, O. and Muller, RH. 2004. Pharmaceutical Biotechnology. Wiley VCH, Weinheim, Germany.

Oxender, D. and Post, L. 1999. Novel Therapeutics from Modern Biotechnology. Springer Verlag.

Spada, S. and Walsh, G. 2005. Directory of Approved Biopharmaceutical Products. CRC Press, Florida, USA.


Mayhall, E., Paffett-Lugassy N., and Zon L.I. 2004. The clinical potential of stem cells. Current Opinion in Cell Biology 16, 713-720.

Reichert, J. and Paquette, C. 2003. Therapeutic recombinant proteins: trends in US approvals 1982-2002. Current

Opinion in Molecular Therapy 5, 139-147. Reichert, J. and Pavlov, A. 2004. Recombinant therapeutics - success rates, market trends and values to 2010.

Nature Biotechnology 22, 1513-1519. Walsh, G. 2005. Biopharmaceuticals: recent approvals and likely directions. Trends in Biotechnology 23, 553558.

Walsh, G. 2006. Biopharmaceutical benchmarks 2006. Nature Biotechnology 24, 769-776. Weng, Z. and DeLisi, C. 2000. Protein therapeutics: promises and challenges of the 21st century. Trends in Biotechnology 20, 29-36.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment